Interdental Plaque Reduction and Periodontitis
- Conditions
- Periodontitis
- Registration Number
- NCT04527913
- Lead Sponsor
- University of Pisa
- Brief Summary
To determine the efficacy of four different oral hygiene protocols involving adjunctive interdental cleaning devices in periodontal patients in terms of plaque and gingival inflammatory scores.
- Detailed Description
Patients included in the study will undergo a thorough clinical examination aiming at collecting all the data desired: periodontal parameters of Probing Pocket Depth (PPD), presence of recession of the gingival margin (Rec) and full mouth plaque score (FMPS) will be recorded on six sites/tooth by a single calibrated examiner using a University of North Carolina (UNC) 15-mm periodontal probe by a calibrated examiner blind to group allocation.
Gingival index (GI) and angulated bleeding score (AngBS) will be recorded at four sites/tooth.
For GI the following scale will be used:
0 normal appearance of gingiva, no bleeding, no inflammation;
1. slight change and moderate edema with slight change in texture, no bleeding, mild inflammation;
2. redness hypertrophy, or edema and glazing, bleeding on probing, moderate inflammation;
3. marked redness, hypertrophy, or edema, ulceration, spontaneous bleeding, severe inflammation.
For AngBS the following scale will be used:
0: no bleeding;
1. bleeding upon probe stimulation;
2. spontaneous bleeding
Consequently, interdental plaque score (IPS), interdental gingival index (IGI), and interdental angulated bleeding score (IAngBI) will be calculated.
Patients will be followed through a five-week period. The timepoints will be the following: T -7 (oral hygiene instructions), T0 (professional supragingival scaling and polishing), T14, T28.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- males or females of age range between 18 and 70 years,
- good health status,
- presence of at least 20 natural teeth
- residual periodontal pockets with PPD≥4mm, in need of specific oral hygiene regimen.
- pregnancy or breast-feeding,
- indication to antibiotic therapy prior to treatment,
- chronic infections,
- systemic diseases (including cardiovascular, pulmonary, cerebral, and metabolic diseases),
- not willing to give a consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method FMPS Full-mouth plaque score (FMPS) Measured at: Baseline, at 1 week, at 3 weeks, and at 5 weeks Changes in FMPS, measured orally through clinical examination. Unit of measure: N
- Secondary Outcome Measures
Name Time Method Clinical attachment level (CAL) Measured at Baseline and at 5 weeks Changes in CAL, measured orally through clinical examination. Unit of measure: mm
Gingival Index (GI) Measured at: Baseline, at 1 week, at 3 weeks, and at 5 weeks Changes in GI, measured orally through clinical examination. Unit of measure: scale from 0 (normal) to 3 (Marked redness, hypertrophy, or edema, ulceration)
Pocket probing depth (PPD) Measured at Baseline and at 5 weeks Changes in PPD, measured orally through clinical examination. Unit of measure: mm
Recession of the gingival margin (REC) Measured at Baseline and at 5 weeks Changes in REC, measured orally through clinical examination. Unit of measure: mm
Angulated bleeding score (AngBS) Measured at: Baseline, at 1 week, at 3 weeks, and at 5 weeks Changes in AngBS, measured orally through clinical examination. Unit of measure: scale from 0 (no bleeding), 1 (bleeding upon probe stimulation) to 2 (spontaneous bleeding).
Trial Locations
- Locations (1)
University Hospital of Pisa
🇮🇹Pisa, Italy
University Hospital of Pisa🇮🇹Pisa, Italy
